(secondQuint)SHIFT: Studying HIV Immunology After Fecal Transplant.

 This study is designed to test the safety and tolerability of Fecal Microbiota Transplant (FMT) in HIV infected individuals on stable antiretroviral therapy (ART).

 Additionally, the study will examine potential effects of FMT on HIV immune activation, which has been linked to HIV disease progression.

.

 SHIFT: Studying HIV Immunology After Fecal Transplant@highlight

SHIFT is a randomized, longitudinal, prospective, blinded, three-arm study to determine the safety and tolerability of Fecal Microbiota Transplant (FMT) in HIV-infected participants on stable antiretroviral therapy (ART).

